Special Issues

Topic Collection: Minimally Invasive Surgery in Gynecological Oncology

· Topical Collection Issue Flyer

Name:  Yoichi Aoki, MD, PhD

Affiliation: Department of Gynecological Oncology, Cancer Institute Hospital, Tokyo, Japan

Website E-Mail

Interests: Gynaecological surgery, Robotic surgery, Laparoscopic surgery

Name:  Gabriele Siesto, MD, PhD

Unit of gynecology, Humanitas Research Hospital, Rozzano, Italy

Website E-Mail

Interests: Applicazione della chirurgia mininvasiva/robotica nel trattamento dell'endometriosi pelvica profonda; Applicazione della chirurgia mininvasiva/robotica nel trattamento della recidiva di prolasso genitale; Chirurgia laparoscopica/robotica nella paziente con elevato profilo di rischio anestesiologico o con obesità patologica; Applicazione della chirurgia mininvasiva/robotica nel trattamento dei tumori maligni ginecologici allo stadio iniziale; Ruolo della chirurgia mininvasiva/robotica nel trattamento dei tumori ginecologici avanzati dopo chemioterapia neo-adiuvante

Name:  Kristin L Bixel, MD

The Ohio State University Wexner Medical Center, Columbus, United States

Website E-Mail

Interests: Gynecologic Oncology

Name:  Gaetano Valenti

Department of General Surgery and Medical Surgical Specialties, University of Catania, Catania, Italy

Website E-Mail

Interests: Ovarian cancer; Gynaecology Oncology; Pelvic surgery

Name:   Vanna Zanagnolo

Gynecology Department, European Institute of Oncology (IEO), Milan, Italy

Website E-Mail

Interests:  Endometrial, Ovarian, Cervical, Vulvar and vaginal carcinoma 

Name:   Scott M. Eisenkop

Women's Cancer Center, Southern California, 4835 Van Nuys Blvd, Suite 208, Sherman Oaks, CA 91403, USA

Interests:  Hysterectomy; Lymph Node Dissection; Robot Assisted Surgery 

Topical Collection Information

Dear Colleagues,

In the twentieth century, gynecological surgery has evolved from open laparotomy for malignant tumors to laparoscopic hysterectomy, which rose in popularity in the 1990s. In 2000, the number of robotic surgery cases began to increase rapidly, and it has now become widespread.

The usefulness of laparoscopic surgery in early-stage endometrial cancer was shown in the LAP2 study, and now, minimal invasive surgery (MIS) plays a large role in gynecological surgery. Contrary to expectations, however, the LACC trial showed that in cervical cancer, MIS resulted in a poorer prognosis than open surgery, and the causes remain to be identified.

From the evolution of MIS as a diagnostic tool to its use as a definitive treatment, MIS, which lessens the burden on patients, is expected to play a major role in the effective use of the limited medical resources in the world today. The theme of this Top Collection of the European Journal of Gynaecological Oncology is “minimally invasive surgery in gynecologic oncology”, wherein new information on MIS and the latest information from experts is provided in the hope of MIS contributing to patient benefit.

Yoichi Aoki, MD, PhD

Guest Editor


Manuscript Submission Information

Manuscripts should be submitted online at https://ejgo.imrpress.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. European Journal of Gynaecological Oncology is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1250. We normally offer a discount greater than 30% (APC: $850) to all contributors invited by the Editor-in-Chief, Guest Editor (GE) and Editorial board member. Submitted papers should be well formatted and use good English.


laparoscopic surgery, hysteroscopy, vaginal surgery, ovarian cancer, endometrial cancer, cervical cancer

Share This Special Issue


Please wait a minute...
For Selected: Toggle Thumbnails
Stage IA endometrial cancer recurrence around the ureter after laparoscopic surgery
Rikiya Sano, Yoshiaki Ota, Soichiro Suzuki, Takuya Moriya, Mitsuru Shiota
European Journal of Gynaecological Oncology    2021, 42 (2): 360-364.   DOI: 10.31083/j.ejgo.2021.02.2292
Abstract35)      PDF(pc) (2310KB)(3)       Save

Minimally invasive surgery has become a standard treatment for early-stage endometrial cancer. Its outcomes are not inferior to those of open surgery, and it has a good prognosis. Thus, there have been a few studies on recurrence patterns in low-risk endometrial cancer. We described the case of a 45-year-old multiparous woman with the International Federation of Gynecology and Obstetrics stage IA, grade 1 endometrioid endometrial cancer, who was treated with laparoscopic modified radical hysterectomy with bilateral adnexectomy and pelvic lymph node dissection. The patient developed isolated recurrence around the left ureter 27 months later, which was also laparoscopically resected. Pathologically, she had a low risk of recurrence; therefore, we had to review our surgical procedures. The findings of a recent study have led to the development of the theory that there is a laparoscopy-specific recurrence pattern. We discussed this recurrence pattern in relation to our patient's case and aimed that our findings will prompt to reconsider laparoscopic surgery in preventing tumor spread and recurrence in early-stage low risk endometrial cancer.
Related Articles | Metrics
Introduction of minimally invasive surgery for the treatment of endometrial cancer in Japan: a review
Yuichiro Miyamoto, Michihiro Tanikawa, Kenbun Sone, Mayuyo Mori-Uchino,Tetsushi Tsuruga, Yutaka Osuga
European Journal of Gynaecological Oncology    2021, 42 (1): 10-17.   DOI: 10.31083/j.ejgo.2021.01.2264
Abstract215)   HTML36)    PDF(pc) (191KB)(80)       Save

Minimally invasive surgery is now becoming the standard surgical method for early stage endometrial cancer. In this review, we describe the path minimally invasive surgery has travelled from being an exceptional treatment to be the current standard in Japan. At the beginning of the 21th century, laparoscopic surgery has been employed for the treatment of gynecologic malignancies including cervical cancer and endometrial cancer. Robotic-assisted surgical system, which appeared a little later than laparoscope, has begun to be actively applied to surgical treatments for gynecologic malignancies that require particularly elaborate technologies. Both laparoscopic and robotic surgery have attracted the attention of surgeons because they enable safe, precise and less invasive surgery. Since the safety of minimally invasive surgery depends largely on the skill and experience of the surgeon, there is an urgent need to establish an educational system for implementing minimally invasive surgery. Here we describe various issues regarding minimally invasive surgery that Japan is currently facing, such as the medical economy, regulations by the Japanese health insurance system, a shortage of surgeons, the roles of academic organizations to educate surgeons and guide the appropriate implementation of minimally invasive surgery.
Related Articles | Metrics
The current evidence for the use of minimally-invasive surgery in endometrial cancer
Joseph J. Noh, Tae-Joong Kim
European Journal of Gynaecological Oncology    2021, 42 (1): 18-25.   DOI: 10.31083/j.ejgo.2021.01.2297
Abstract146)   HTML25)    PDF(pc) (194KB)(71)       Save

The aim of the present study is to review the current available data regarding the use of minimally-invasive surgery in endometrial cancer patients and investigate the feasibility and safety of it for cancer control. We also reviewed the current understanding of sentinel lymph node mapping and the use of robotic surgery in endometrial cancer. Studies have consistently demonstrated better short-term outcomes of minimally-invasive surgery in endometrial cancer compared to laparotomy such as less blood loss, shorter hospital stay, and fewer wound complications. Large randomized clinical trials and meta-analyses also suggest the feasibility and safety of minimally-invasive surgery in terms of oncologic outcomes especially in patients with early stage disease. Although evidence for advanced stage disease and patients with high risk for recurrence are still lacking, the current available data seem to support the use of minimally-invasive surgery for those patient groups as well. A large body of literature supports the role of sentinel lymph node mapping in endometrial cancer with a high sensitivity and a low false negative rate, as well as a favorable negative predictive value. Studies also show that robotic surgery is a safe and effective alternative to conventional laparoscopic surgery for endometrial cancer staging but further long-term data are required. Further prospective studies with long-term follow-up are warranted to evaluate the feasibility and safety of minimally-invasive surgery especially in patients with advanced stage disease and high risk for recurrence. However, the current available data support the use of minimally-invasive surgery in all patient groups of endometrial cancer.
Related Articles | Metrics
Surgical approach in early stage cervical cancer: the Asian view point
Hiroko Machida, Hiroshi Yoshida, Kenji Izumi, Rie Nakajima, Miwa Yasaka, Tetsuji Iida, Masae Ikeda, Masako Shida, Takeshi Hirasawa, Mikio Mikami
European Journal of Gynaecological Oncology    2021, 42 (1): 30-37.   DOI: 10.31083/j.ejgo.2021.01.2270
Abstract138)   HTML13)    PDF(pc) (800KB)(62)       Save

Objective: To examine the current practice of radical hysterectomy for early-stage cervical cancer in Asia after the Laparoscopic Approach to Cervical Cancer (LACC) trial. Methods: A cross-sectional study was conducted in Asia to examine the prevalence and management of women with early-stage cervical cancer. The study was conducted among gynecologic oncologists at leading hospitals in the Asian Society of Gynecologic Oncology Council members. A systematic literature review was performed to examine the association between survival outcomes and surgical approach after the LACC trial. Results: Seven countries participated voluntarily in the study. The incidence, mortality, and centralization of treatment in early-stage cervical cancer were different among the seven countries. The number of specialized centers per population density in Japan was higher than that in the other countries. Minimally invasive surgery (MIS) approach for cervical cancer was common in Korea (56%) and Hong Kong (80-90%), but not in the other countries (2-20%). In the systematic review, there was a significant difference in survival outcomes between MIS and open surgery (recurrence, hazard ratio 1.83, 95% confidence interval 1.27-2.62). MIS without a uterine manipulator or making a vaginal cuff closure produced similar recurrence rates compared with open surgery (MIS without uterine manipulator vs open-surgery: 10.5% vs 10.1%, and MIS with cuff closure vs open-surgery 7.2% vs 10.1%; all P > 0.05). Conclusion: The prevalence of MIS for early-stage cervical cancer varies across Asian regions after the LACC trial. Surgical methods to avoid tumor spillage may be useful for improving survival.
Supplementary Material | Related Articles | Metrics
Short-term outcomes for patients with endometrial cancer who received robot-assisted modified radical hysterectomy: A retrospective observational study
Tomohito Tanaka, Shoko Ueda, Shunsuke Miyamoto, Shinichi Terada, Hiromi Konishi, Yuhei Kogata, Satoe Fujiwara, Yoshimichi Tanaka, Kohei Taniguchi, Kazumasa Komura, Masahide Ohmichi
European Journal of Gynaecological Oncology    2021, 42 (1): 90-95.   DOI: 10.31083/j.ejgo.2021.01.2262
Abstract124)   HTML8)    PDF(pc) (473KB)(59)       Save

Objective: Minimally invasive surgery is a standard treatment for endometrial cancer patients with uterine-confined disease. Robot-assisted surgery has been covered under public insurance since 2018 in Japan. The aim of the current study was to compare the short-term outcomes between robot-assisted modified radical hysterectomy (RAMRH) and total laparoscopic modified radical hysterectomy (TLMRH). Methods: A total of 190 patients with endometrial cancer who had undergone RAMRH or TLMRH were retrospectively reviewed. Short-term outcomes, including surgical time, estimated blood loss, complications, and hospital stay, were compared between the groups. Results: Among 190 patients, including 67 with RAMRH and 123 with TLMRH, the median (interquartile range [IQR]) surgical time was 247 (IQR: 221-313) min in RAMRH and 271 (IQR: 236-280) min in TLMRH. The estimated blood loss was less than 10 mL in most cases. There was 1 major vessel injury and 1 vescio-vaginal fistula in the RAMRH group. In contrast, there were 2 bladder injuries, 1 bowel injury, 2 obturator nerve injuries, 1 major vessel injury, and 2 pelvic abscesses in the TLMRH group. The median hospital stay was 10 (IQR: 10-10) days in RAMRH and 9 (IQR: 9-10) days in TLMRH. Conclusion: Robot-assisted procedures were not associated with poorer short-term outcomes than laparoscopy in patients with endometrial cancer.
Related Articles | Metrics
The impact of post-operative voiding trial on length of stay following laparoscopic hysterectomy: a prospective, randomized control trial
Michelle Davis, Kathryn Barletta, Alexcis Ford, Roni Nitecki, Kevin M. Elias, Ross Berkowitz, Colleen Feltmate
European Journal of Gynaecological Oncology    2021, 42 (1): 110-117.   DOI: 10.31083/j.ejgo.2021.01.2293
Abstract103)   HTML9)    PDF(pc) (1794KB)(57)       Save

Objective: Same day discharge (SDD) is feasible following laparoscopic hysterectomy (TLH) in gynecologic oncology patients resulting in low complication and re-admission rates. Following vaginal surgery, backfill or active voiding trials have been shown to reduce hospital discharge with a catheter. The aim of this study is to determine if performing an active backfill voiding trial (AVT) vs. passive voiding trial (PVT) leads to expedited discharge following TLH. Methods: Subjects scheduled for SDD TLH were enrolled and randomized to an AVT or a PVT. The primary outcome was length of stay. Secondary outcomes include time to void, catheter replacement, admission to the extended recovery unity (ERU), post-operative pain, and complications. Results: 121 patients were randomized: 60 to an AVT and 61 to a PVT. There was a statistically significant reduction in median length of stay for patients undergoing an AVT vs. PVT (271.5 minutes vs. 329 minutes, P = 0.015). Median time to void was also decreased with an AVT vs. PVT (30 minutes vs. 289 minutes, P < 0.001). There was no difference in median pain score (2), catheter replacement, peri-operative complications, or overnight admissions between the two groups. Conclusion: There is a significant reduction in time to void and total length of stay in patients randomized to a backfill voiding trial following TLH with no increased patient discomfort. While the numbers of post-operative admissions were low and underpowered to detect a difference in admission rate, these data will help to streamline post-operative care for SDD gynecologic oncology patients.
Supplementary Material | Related Articles | Metrics
Study of laparoscopic monopolar devices and its thermal effects
Motoki Matsuura, Masato Tamate, Sachiko Nagao, Muna Nishio, Tadahi Okada, Yoko Nishimura, Kyoko Isoyama, Noriko Terada, Tsuyoshi Saito
European Journal of Gynaecological Oncology    2021, 42 (1): 118-121.   DOI: 10.31083/j.ejgo.2021.01.2311
Abstract81)   HTML5)    PDF(pc) (971KB)(51)       Save

Objective: Energy devices are frequently used in minimally invasive surgeries (MIS). For MIS involving gynecologic malignancies, energy devices should be used cautiously to prevent thermal injuries to nearby organs. We evaluated monopolar electrosurgery devices and measured increases in temperature in the tissue and device. Methods: Briefly, the surface of a porcine tissue was incised using short and long activation times. Subsequently, the maximum temperature at the tip of the monopolar device, the cooling time required to reach a temperature of 60 °C, and the maximum tissue temperature were recorded. Results: Longer activation time was correlated with a higher tip temperature. With all activation times, there was an increase in the tip temperature that exceeded 100 °C. The cooling time to reach 60 °C was faster with the short activation times than with the long activation times. Even with the same output, the temperature decreased faster in the coagulation mode, suggesting that the cooling times were shorter with lower outputs. The tissue temperature dropped to 60 °C or less within 1 s in the cut mode but required approximately 2 s in the coagulation mode at 40 W. The temperature of the dissected tissue increased to 60 °C or higher; the cooling time was longer with high output and in the coagulation mode. Conclusions: We revealed that the activation of the monopolar device under routine use conditions exceeded a temperature of 100 °C. Additionally, the temperatures of the tip and tissue were significantly higher in proportion to the output and time. For MIS involving gynecologic malignancies, careful attention is necessary to avoid thermal injury.
Related Articles | Metrics
Outcomes and complications of total laparoscopic hysterectomy after conization
Kaori Hoshino, Yasuyuki Kinjo, Hiroshi Harada, Taeko Ueda, Yoko Aoyama, Midori Murakami, Seiji Kagami, Yusuke Matsuura, Kiyoshi Yoshino
European Journal of Gynaecological Oncology    2021, 42 (1): 122-128.   DOI: 10.31083/j.ejgo.2021.01.2319
Abstract76)   HTML6)    PDF(pc) (187KB)(62)       Save

Objective: High-grade squamous intraepithelial lesion (HSIL)/cervical intraepithelial neoplasia (CIN) 3, and stage IA1 cervical cancer are often diagnosed after cervical conization. Additional resection is required in some cases, and total laparoscopic hysterectomy (TLH) after conization requires attention due to the postoperative changes around the cervix. Methods: This single-center retrospective study investigated the perioperative outcomes and complications of TLH with or without conization. Patients diagnosed with CIN or stage IA1 cervical cancer were grouped according to whether conization was performed before TLH. The perioperative outcomes, complications, and oncological outcomes were compared for 32 patients who underwent TLH after conization (cone-TLH group) and 18 patients who underwent TLH alone (TLH group). Results: The mean interval between conization and TLH was 14.8 ± 5.2 weeks. There were no significant differences between the cone-TLH and TLH groups in terms of surgical time (186.3 ± 48.1 min vs. 179.8 ± 34.6 min, P = 0.61), blood loss (100 [5-500] mL vs. 100 [5-560] mL, P = 0.79), length of hospital stay (4.7 ± 1.4 days vs. 4.6 ± 1.0 days, P = 0.86), or recurrence rate. One patient in the cone-TLH group experienced a ureter injury. Conclusions: Although the outcomes were comparable between TLH alone and TLH after conization, care is needed to avoid ureter complications.
Related Articles | Metrics
Cesarean scar perforation in laparoscopic hysterectomy for endometrial cancer: a case report
Azusa Kimura, Kenro Chikazawa, Ken Imai, Ito Takaki, Tomoyuki Kuwata, Ryo Konno
European Journal of Gynaecological Oncology    2021, 42 (1): 179-182.   DOI: 10.31083/j.ejgo.2021.01.2256
Abstract246)   HTML24)    PDF(pc) (935KB)(81)       Save

Perioperative complications tend to increase when performing hysterectomy in patients with a history of caesarean section. Therefore, the laparoscopic hysterectomy procedure requires careful consideration. Herein, we report the case of a patient with a history of caesarean section who underwent total laparoscopic hysterectomy for endometrial cancer. A 59-year-old woman was diagnosed with stage IA endometrial cancer preoperatively, and she underwent laparoscopic hysterectomy, bilateral adnexectomy, and pelvic lymphadenectomy. During these procedures, the bladder was observed to tightly adhere to the scar of a previous caesarean section, and the uterine was perforated due to detachment near the uterus to avoid damage to the bladder. After 2 years, there were no symptoms of recurrence. Our findings further demonstrated that bladder adhesions should be considered in laparoscopic surgery for patients with endometrial cancer who have a history of caesarean section.
Related Articles | Metrics
A modified technique of laparoscopic radical trachelectomy combined with extracorporeal cervical amputation through a mini-laparotomy
Zen Watanabe, Hideki Tokunaga, Masumi Ishibashi, Shogo Shigeta, Keita Tsuji, Tomoyuki Nagai, Masahito Tachibana, Muneaki Shimada, Nobuo Yaegashi
European Journal of Gynaecological Oncology    2021, 42 (1): 183-188.   DOI: 10.31083/j.ejgo.2021.01.2278
Abstract85)   HTML13)    PDF(pc) (2991KB)(95)       Save

Radical trachelectomy is an optional fertility-sparing treatment for early-stage cervical cancer, and recently, the minimally invasive approach (MIA) has become a major trend in radical trachelectomy. MIA radical trachelectomy requires a more careful surgical technique to avoid tumor spillage and exposure of the cancerous tissue under carbon dioxide pneumoperitoneum to reduce the risk of recurrence. We present a case of a 33-year-old nulliparous woman with stage IB1 cervical cancer who underwent MIA radical trachelectomy through a combination of laparoscopic surgery and mini-laparotomy, mainly to prevent postoperative complications and tumor spread during cervical amputation. A Papanicolaou test suggested the diagnosis of squamous cell carcinoma of the cervix without any symptoms such as atypical bleeding. The subsequent biopsy revealed squamous cell carcinoma with stromal invasion of the cervix. Cervical amputation was performed extracorporeally through a small incision in the lower abdomen. There were no perioperative complications. The patient was discharged on postoperative day 13. The final pathological evaluation revealed residual microinvasive cancer of the endocervical canal with clear margins, no lymphovascular space involvement, and 27 negative lymphatic nodes. The joint of the neo-cervix and vagina had healed completely without erosion or stenosis of the cervical canal, and no problems occurred during sexual intercourse. No cancer recurrence or menstrual disorders have been reported in the short postoperative period of 6 months. The surgical technique of laparoscopic radical trachelectomy combined with extracorporeal cervical amputation may be an acceptable alternative to reduce the risk of recurrence by preventing intraperitoneal tumor spillage.
Related Articles | Metrics
Robotic hysterectomy with pelvic lymphadenectomy for early endometrial cancer in a patient with situs inversus totalis using 3D-CT analysis: a case report
Hideaki Yajima, Eiji Kondo, Masafumi Nii, Michiko Kaneda, Kenta Yoshida, Tomoaki Ikeda
European Journal of Gynaecological Oncology    2021, 42 (1): 189-192.   DOI: 10.31083/j.ejgo.2021.01.2294
Abstract89)   HTML13)    PDF(pc) (13408KB)(44)       Save

Background: Pelvic lymphadenectomy should be considered the standard of care for endometrial cancer patients with intermediate-risk. In such cases, lymph node assessment may be performed via a minimally invasive approach. Situs inversus totalis is a congenital condition wherein the major visceral organs are reversed or mirrored from their normal anatomical positions. Reports state that performing surgery on patients with this condition is difficult due to the anatomical abnormality. However, few clinical studies have been conducted to evaluate the efficacy of robotic surgery for endometrial cancer patients with situs inversus totalis because it is technically challenging. Case presentation: A 69-year-old woman with situs inversus totalis (gravida 2 para 2) was brought to our hospital due to a uterine tumor. Endometrial biopsy showed grade 1 endometrioid carcinoma. Using 3 dimensional -computed tomography reconstruction, her common iliac arteries and veins were found to be reversed or mirrored from their normal positions. She underwent hysterectomy with pelvic lymphadenectomy using the multi-articulated arms or 3 dimensional high-definite vision of the da Vinci® surgical system, and 19 lymph nodes were harvested. She was followed up for 24 months without signs of recurrence. Conclusion: The multi-articulated arms or 3 dimensional high-definite vision of the da Vinci® surgical system may be a feasible and safe approach for performing a pelvic lymphadenectomy on patients with situs inversus totalis using 3 dimensional computed tomography analysis.
Related Articles | Metrics
Laparoscopic ureteral reconstruction in gynaecological recurrent cancer surgeries: an initial case series study
Yuji Tanaka, Yusuke Shimizu, Ai Ikki, Kota Okamoto, Atsushi Fusegi, Makoto Nakabayashi, Makiko Omi, Tomoko Kurita, Terumi Tanigawa, Yoichi Aoki, Sachiho Netsu, Mayu Yunokawa, Hidetaka Nomura, Maki Matoda, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao
European Journal of Gynaecological Oncology    2020, 41 (6): 975-981.   DOI: 10.31083/j.ejgo.2020.06.2258
Abstract99)   HTML3)    PDF(pc) (1940KB)(72)       Save

In combined resection of the bladder and ureter during laparoscopic surgery for gynaecological recurrent cancer, some cases require laparoscopic ureteral reconstruction techniques. In the open surgery approach, it has been reported that gynaecological advanced or recurrent tumour surgeries solely conducted by a gynaecologic group, with combined resection of multiple organs, improves the prognosis. However, to the best of our knowledge, in the minimally invasive surgery approach, there are no reported case series in the field of gynaecological recurrent tumour surgery conducted by only a gynaecologic group, with combined resection of the bladder and ureter. Therefore, we conducted this pilot study to describe the feasibility of laparoscopic gynaecologic recurrent malignant tumour surgery involving ureteral reconstruction. We retrospectively searched our patient database for women with gynaecological cancer who underwent laparoscopic ureteral reconstruction techniques in gynaecological recurrent cancer surgeries. Nine patients underwent laparoscopic ureteral reconstruction for long-segment ureteral defects in gynaecologic surgeries. In all cases, R0 surgical resection were successfully performed. The ureteral defect lengths ranged from 3.5-10 cm (median, 4 cm). The Boari flap was necessary in one of the eight cases with a ureteral defect of less than 8 cm. The ureteral defect was less than 12 cm in all cases, but substitution was required in three cases. In all cases except one, no urinary complications occurred. In conclusion, it is feasible for a gynaecologist to perform laparoscopic ureteral reconstruction combined resection of the bladder and ureter during laparoscopic surgery for gynaecological recurrent cancer.
Related Articles | Metrics
Human papillomavirus genotyping is a reliable prognostic marker of recurrence for high-grade cervical intraepithelial neoplasia (CIN2-3) with positive margins after loop electrosurgical excision procedure
Ha Na Yun, Woo Dae Kang, U Chul Ju, Seok Mo Kim
European Journal of Gynaecological Oncology    2020, 41 (6): 969-974.   DOI: 10.31083/j.ejgo.2020.06.2231
Abstract84)   HTML5)    PDF(pc) (175KB)(54)       Save

Objective: The study was performed to determine whether the human papillomavirus (HPV) genotype result from the HPV DNA chip test (HDC) was predictive of recurrent high-grade cervical intraepithelial neoplasia (CIN2-3) in patients with positive margins after a loop electrosurgical excision procedure (LEEP). Methods: A total of 184 patients with histologically confirmed CIN2-3 identified at the margin of a LEEP specimen were followed with HDC testing, hybrid capture II (HC2) analysis, and cytology examinations. Post-LEEP monitoring was conducted at 3, 6, 9, 12, 18, and 24 months during the first two years and annually thereafter. Results: Of the 184 patients, the HC2 test was positive in 179 patients (97.3%) and the HDC test was positive in 181 patients (97.6%) before the LEEP. The overall agreement between the HC2 and HDC tests was 98.9%. Forty-six (25.0%) patients developed a recurrence, and those who experienced a relapse tested positive for the same high-risk HPV genotype detected before the LEEP. Identifying the same high-risk HPV genotype by HDC testing during the follow-up period had a negative predictive value and a sensitivity of 100% in diagnosing recurrent lesions. HPV-18 was related to recurrent CIN2-3. A significant association between HPV-18 infection and recurrent CIN2-3 was found (p < 0.05). Conclusions: In patients with CIN2-3 identified at the margins of a LEEP specimen, the persistence of the same high-risk HPV infection, especially HPV-18, should be regarded as a risk factor for recurrent CIN2-3. After a LEEP, such patients require particular attention with short-term follow-up.
Related Articles | Metrics
Minimally invasive surgery in radical hysterectomy for cervical cancer
Chyi-Long Lee, Kuan-Gen Huang, Peng-Teng Chua
European Journal of Gynaecological Oncology    2020, 41 (6): 852-857.   DOI: 10.31083/j.ejgo.2020.06.2260
Abstract186)   HTML33)    PDF(pc) (1663KB)(140)       Save
Related Articles | Metrics
Complete resection of an endometrial cancer lesion by hysteroscopic tumor resection combined with photodynamic diagnosis: a case report
Yusuke Matoba, Kouji Banno, Yusuke Kobayashi, Kosuke Tsuji, Iori Kisu, Daisuke Aoki
European Journal of Gynaecological Oncology    2020, 41 (6): 1050-1055.   DOI: 10.31083/j.ejgo.2020.06.2204
Abstract76)   HTML5)    PDF(pc) (6692KB)(53)       Save

Introduction: Treatment for early endometrial cancer (EC) has been shifting to less invasive surgery, including several reports of hysteroscopic tumor resection. Complete tumor resection is desired in these treatments. Photodynamic diagnosis (PDD) is the technique to increase the complete resection rate by red fluorescence of the lesion and has improved the prognosis of cystoscopic tumor resection for early bladder cancer. In gynecology, we showed that hysteroscopic PDD has high sensitivity for EC. Here, we report a case of EC in which no residual malignant lesions were found pathologically in hysterectomy after hysteroscopic tumor resection with PDD. Case: The patient was 54 years old when she was diagnosed with atypical endometrial hyperplasia by endometrial biopsy, but suspected to have EC on magnetic resonance imaging. Hysteroscopic tumor resection was planned for the definitive diagnosis. PDD was used in hysteroscopic surgery after informed consent was obtained. Under hysteroscopy, a tumefactive lesion was found on the anterior wall of the uterine cavity to near the left oviductal orifice, and was PDD-positive. The PDD-positive lesion was resected completely under hysteroscopy. The hysteroscopic specimen was pathologically diagnosed as endometrioid carcinoma, grade 1. Laparoscopic hysterectomy and bilateral salpingo-oophorectomy were then performed, but no residual malignancy was found in resected specimens. There has been no recurrence at one year after surgery without no adjunct therapy. Conclusion: Complete resection of endometrial cancer was achieved by hysteroscopic tumor resection with PDD. This case suggests that hysteroscopic surgery may be a less invasive treatment option for early EC.
Related Articles | Metrics

Current Issue

  • Volume 42, Issue 2